NanoViricides Inc (NNVC)

[drkazmd65]

Phase I trials mostly are focused on 'safety' profiles and in testing out different dosages, so yeah - I think that's going to be the primary goal here as well. But some inkling of what other sorts of data they intend to collect and how they plan to use that data to (hopefully) design a more extensive Phase II would be nice to see ahead of time.

Hopefully just getting a Phase I trial going in India will be enough to 'goose' the share prices enough that we won't get as big of a dilution for existing shareholders, or that that's enough to encourage a trial partnership with some other bigger pharma for the herpes-cides.

I think your take here is correct KMBJN. I am cautiously optimistic that we might finally start to see something moving after way too many years of bupkis.